Charanraj Goud Alladi

5PUBLICATIONS
14CO-AUTHORS
Nutrigenomics and personalised nutritionRegenerative medicine (incl. stem cells)PharmacogenomicsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 28, 2026
Nutraceuticals for the Management of Cardiovascular Health: A Mechanistic and Evidence-Based Review Focusing on Atherosclerosis and Hypertension.

|Mar 15, 2023
Risperidone response in patients with schizophrenia drives DNA methylation changes in immune and neuronal systems.

Ana Lokmer, Charanraj Goud Alladi, Réjane Troudet

|Feb 14, 2023
Impact of pharmacogenomics in achieving personalized/precision medicine in the clinical setting: a symposium report.

Reka Devanathan, Charanraj Goud Alladi, Mirunalini Ravichandran

|Oct 18, 2018
Dopamine (DRD2) and Serotonin (HTR2A, 2C) Receptor Gene Polymorphisms do not influence early response to Risperidone in South Indian Patients with Schizophrenia.

Charanraj Goud Alladi, Ravi Philip RajKumar, Surendiran Adithan

|Oct 06, 2018
DNA Methylation as a Biomarker of Treatment Response Variability in Serious Mental Illnesses: A Systematic Review Focused on Bipolar Disorder, Schizophrenia, and Major Depressive Disorder.

Charanraj Goud Alladi, Bruno Etain, Frank Bellivier

Pageof 1

Frequent Collaborators

2 joint publications

Cynthia Marie-Claire

1 joint publications

Frank Bellivier

1 joint publications

Chakradhara Rao S Uppugunduri

1 joint publications

Ana Lokmer